nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

17.01.2018 | Editorial (by Invitation)

Should we stop anti-thrombotic agents prior to vitrectomy?

verfasst von: David Yorston, David Wong, Antonia Joussen

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

All retinal surgeons are occasionally faced with the dilemma of operating on a patient who is taking anti-thrombotic medication. Although there is clear guidance that anti-thrombotics pose little risk in cataract surgery, the situation is more confused when it comes to vitreoretinal surgery [1], and there are wide variations in practice. Vitrectomies are more likely to be affected by haemorrhagic complications than clear cornea phacoemulsification, and the consequences of bleeding into the eye during a vitrectomy can be very serious. The paper by Meillon & colleagues goes some way towards reducing our confusion. …

Patel R, Charles S, Jalil A (2017) Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review. Graefes Arch Clin Exp Ophthalmol 255:1275–1285CrossRefPubMed

Ryan A, Saad T, Kirwan C, Keegan DJ, Acheson RW (2013) Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery. Clin Exp Ophthalmol 41:387–395CrossRefPubMed

Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D (2008) Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol 92:365–368CrossRefPubMed

Smith JM, Steel DH (2015) Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy. In: Steel DH, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; p. CD008214

Titel: Should we stop anti-thrombotic agents prior to vitrectomy?
verfasst von: David Yorston
David Wong
Antonia Joussen
Publikationsdatum: 17.01.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-017-3898-0

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Should we stop anti-thrombotic agents prior to vitrectomy?

Excerpt

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Short-term fluctuation of lens corneal distance and clinical correlation with phacodonesis

MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery

Correction to: Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration

Bilateral lateral rectus recession versus unilateral recession resection for basic intermittent exotropia: a meta-analysis

QUIET PLEASE! Effect of distraction on simulated posterior segment surgical performance

Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde